Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Standard Biotools (LAB) Shares Repurchased (2022 - 2024)

Standard Biotools (LAB) has disclosed Shares Repurchased for 3 consecutive years, with $29.4 million as the latest value for Q2 2024.

  • On a quarterly basis, Shares Repurchased rose 1139.54% to $29.4 million in Q2 2024 year-over-year; TTM through Mar 2025 was $29.4 million, a 110.29% increase, with the full-year FY2024 number at $40.5 million, up 647.88% from a year prior.
  • Shares Repurchased was $29.4 million for Q2 2024 at Standard Biotools, up from $11.1 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $29.4 million in Q2 2024 to a low of $174000.0 in Q4 2023.
  • A 3-year average of $6.6 million and a median of $2.4 million in 2023 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: crashed 69.09% in 2023, then skyrocketed 1139.54% in 2024.
  • Standard Biotools' Shares Repurchased stood at $563000.0 in 2022, then plummeted by 69.09% to $174000.0 in 2023, then surged by 16818.97% to $29.4 million in 2024.
  • Per Business Quant, the three most recent readings for LAB's Shares Repurchased are $29.4 million (Q2 2024), $11.1 million (Q1 2024), and $174000.0 (Q4 2023).